Vitamin K2 (Menatetrenone) induces iNOS in bovine vascular smooth muscle cells: No relationship between nitric oxide production and γ- carboxylation

Journal of Nutritional Science and Vitaminology

Volumn 45, Issue 6, 1999, Pages 711-723

  Sano, Masahiro ^a   Fujita, Hiroshi ^a   Morita, Ikuo ^a   Uematsu, Hiroshi ^a   Murota, Sei Itsu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; iNOS; Smooth muscle cell

Indexed keywords

FARNOQUINONE; GERANYLGERANIOL; MENADIONE; MENATETRENONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; CARBOXYLIC ACID; DRUG DERIVATIVE; HEMOSTATIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; VITAMIN K GROUP;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; CARBOXYLATION; CARDIOVASCULAR SYSTEM; CATTLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; NONHUMAN; OSTEOPOROSIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; ENZYMOLOGY; METABOLISM;

ANIMALIA; BOS TAURUS; BOVINAE;

ANIMALS; CARBOXYLIC ACIDS; CATTLE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; HEMOSTATICS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; VITAMIN K; VITAMIN K 2;

EID: 0033493175     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.45.711     Document Type: Article

References (39)

1. Schmidt HH, Walter U. 1994. NO at work. Cell 78: 919-925.
2. Knowles RG, Moncada S. 1994. Nitric oxide synthase in mammals. Biochem J 298: 249-258.
3. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064.
4. Loscalzo J, Welch G. 1995. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38: 87-104.
5. Lowenstein CJ, Snyder SH. 1992. Nitric oxide, a novel biologic messenger. Cell 70: 705-707.
6. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. 1996. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78: 225-230.
7. Garg UC, Hassid A. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777.
8. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. 1994. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267: C1405-C1413.
9. Koglin J, Glysing-Jensen T, Mudgett JS, Russell ME. 1998. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 97: 2059-2065.
10. McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, Akers DL. 1993. L-Arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun 193: 291-296.
11. Marks DS, Vita JA, Folts JD, Keaney JF Jr, Welch GN, Loscalzo J. 1995. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 96: 2630-2638.
12. Groves PH, Banning AP, Penny WJ, Newby AC, Cheable HA, Lewis MJ. 1995. The effects of exogenous nitric oxide on smooth muscle cell proliferation following pocine carotid angioplasty. Cardiovasc Res 30: 87-96.
13. Seki J, Nishio M, Kato M, Motoyama Y, Yoshida K. 1995. FK409, a new nitric oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis 117: 97-106.
14. Suttie JW. 1965. In: Handbook of Vitamins (Machlin LJ, ed), 2nd ed, p 145-194. Marcel Dekker, New York.
15. Suttie JW. 1985. Vitamin K-dependent carboxylase. Annu Rev Biochem 54: 459-477.
16. Buitenhuis HC, Soute BA, Vermeer C. 1990. Comparison of the vitamin K1, K2 and K3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochem Biophys Acta 1034: 170-175.
17. Dowd P, Ham SW, Naganathan S, Hershline R. 1995. The mechanism of action of vitamin K. Annu Rev Nutr 15: 419-440.
18. Akiyama Y, Hara K, Ohkawa I, Tajima T. 1993. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol 62: 145-153.
19. Hara K, Akiyama Y, Ohkawa I, Tajima T. 1993. Effects of menatetrenone on prednisolonc-induced bone loss in rats. Bone 14: 813-818.
20. 2 on bone loss in ovariectomized rats. Folia Pharmacol Jpn 104: 101-109.
21. 2 on bone resorption may be related to its side chain. Bone 16: 179-184.
22. 2 and serum cholesterol in patients on continuous ambulatory peritoneal dialysis. Lancet 351: 724.
23. 2 on atherosclerosis and blood coagulation in hypercholesterolemic rabbits. Jpn J Pharmacol 75: 135-143.
24. Nakayama DK, Geller DA, Lowenstein CJ, Chern HD, Davies P, Pitt BR, Simmons RL, Billiar TR. 1992. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am J Respir Cell Mol Biol 7: 471-476.
25. Ranjan V, Xiao Z, Diamond SL. 1995. Constitutive nitric oxide synthase protein and mRNA levels are evaluated in cultured human and bovine endothelial cells exposed to fluid shear stress. Am J Physiol 269: H550-H555.
26. Natalia P, Grigori E. 1995. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375: 68-73.
27. Brauman RS, Hendrix SA. 1989. Nagogram nitrite and nitrate determination in environmental and biological materials by vanadium reduction with chemiluminescence detection. Anal Chem 51: 2715-2718.
28. Liao JK, Zulueta JJ, Yu FS, Peng HB, Cote CG, Hassoun PM. 1995. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest 96: 2661-2666.
29. Szabo C, Southan GJ, Thiemermann C. 1994. Beneficial effects and improved survival in rodent models of septic shock with S-methyllisothiourca sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91: 12472-12476.
30. Southan GJ, Szabo C, Thiemermann C. 1995. Amidines are potent inhibitors of nitric oxide synthases: preferential inhibition of the inducible isoform. Br J Pharmacol 291: 311-318.
31. Garvey EP, Oplinger JA, Tanoury GJ. 1994. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 269: 26669-26676.
32. Nakane M, Klinghofer V, Kuk JE. 1995. Novel potent and selective inhibitors of inducible nitric oxide synthases. Mol Pharmacol 47: 831-834.
33. Xie, QW, Whisnant R, Nathan C. 1993. Promotor of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177: 1779-1784.
34. Lowenstein CJ, Alley EW, Raval P, Snyder SH, Russell SW, Murphy WJ. 1993. Macrophage nitric oxide gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730-9734.
35. Chen Q, Cederbaum AI. 1997. Menadione cytotoxicity to Hep G2 cells and protection by activation of nuclear factor-kappaB. Mol Pharmacol 52: 648-657.
36. Iwashita M, Hirata Y, Imai T, Sato K, Marumo F. 1996. Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem 237: 668-673.
37. Hattori Y, Gross SS. 1995. Cycloheximide induces nitric oxide synthase mRNA in vascular smooth muscle cells by prolonging mRNA lifetime. Biochem Mol Biol Int 37: 439-445.
38. Heuze JI, Mennecier P, Simonet S, Laubie M, Verbeuren TJ. 1992. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. Eur J Pharmacol 220: 161-171.
39. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. 1996. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78: 225-230.